AMRX

Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company that develops and delivers a diverse portfolio of generic and specialty pharmaceuticals. The company operates in several segments, including complex generic medicines, biosimilars, injectable medicines, and specialty branded pharmaceuticals, primarily targeting central nervous system and endocrine disorders. Amneal serves various customers, including hospitals, health systems, and retail markets, and distributes products through its AvKARE segment. The company is headquartered in Bridgewater, New Jersey, and has a presence in the United States, India, and Ireland.